Suppr超能文献

干预措施在基层医疗环境中提高骨质疏松症检测和治疗效果的有效性:系统评价和荟萃分析。

Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis.

机构信息

Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.

出版信息

Osteoporos Int. 2011 Nov;22(11):2743-68. doi: 10.1007/s00198-011-1557-6. Epub 2011 Feb 19.

Abstract

This study aims to evaluate the effectiveness of primary care interventions to improve the detection and treatment of osteoporosis. Eight electronic databases and six gray literature sources were searched. Randomized controlled trials, controlled clinical trials, quasi-randomized trials, controlled before-after studies, and interrupted time series written in English or French from 1985 to 2009 were considered. Eligible studies had to include patients at risk (women ≥ 65 years, men ≥ 70 years, and men/women ≥ 50 years with at least one major risk factor for osteoporosis) or at high risk (men/women using oral glucocorticoids or with previous fragility fractures) for osteoporosis and fractures. Outcomes included bone mineral density (BMD) testing, osteoporosis treatment initiation, and fractures. Data were pooled using a random effects model when applicable. Thirteen studies were included. The majority were multifaceted and involved patient educational material, physician notification, and/or physician education. Absolute differences in the incidence of BMD testing ranged from 22% to 51% for high-risk patients only and from 4% to 18% for both at-risk and high-risk patients. Absolute differences in the incidence of osteoporosis treatment initiation ranged from 18% to 29% for high-risk patients only and from 2% to 4% for at-risk and high-risk patients. Pooling the results of six trials showed an increased incidence of osteoporosis treatment initiation (risk difference (RD) = 20%; 95% CI: 7-33%) and of BMD testing and/or osteoporosis treatment initiation (RD = 40%; 95% CI: 32-48%) for high-risk patients following intervention. Multifaceted interventions targeting high-risk patients and their primary care providers may improve the management of osteoporosis, but improvements are often clinically modest.

摘要

本研究旨在评估初级保健干预措施在提高骨质疏松症检测和治疗方面的有效性。我们检索了 8 个电子数据库和 6 个灰色文献来源,纳入了 1985 年至 2009 年间发表的英文或法文的随机对照试验、对照临床试验、准随机试验、对照前后研究和中断时间序列研究。合格研究必须包括有骨质疏松症和骨折风险的患者(女性≥65 岁、男性≥70 岁、男性/女性≥50 岁且至少有一个骨质疏松症的主要危险因素)或高危患者(男性/女性正在服用口服糖皮质激素或有既往脆性骨折)。结果包括骨密度(BMD)检测、骨质疏松症治疗起始和骨折。当适用时,使用随机效应模型对数据进行汇总。纳入了 13 项研究。大多数研究是多方面的,涉及患者教育材料、医生通知和/或医生教育。仅高危患者的 BMD 检测发生率的绝对差异为 22%至 51%,而有风险和高危患者的发生率的绝对差异为 4%至 18%。仅高危患者的骨质疏松症治疗起始的发生率的绝对差异为 18%至 29%,而有风险和高危患者的发生率的绝对差异为 2%至 4%。对 6 项试验的结果进行汇总显示,干预后高危患者的骨质疏松症治疗起始的发生率(风险差异(RD)=20%;95%CI:7-33%)和 BMD 检测和/或骨质疏松症治疗起始的发生率(RD=40%;95%CI:32-48%)增加。针对高危患者及其初级保健提供者的多方面干预措施可能会改善骨质疏松症的管理,但改善通常在临床上较为温和。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验